Pınar Arıcan

Pınar Arıcan

Auto-generated profile, based on publicly available information

Pınar Arıcan

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SBSema Bozkaya-Yilmaz
Sema Bozkaya-Yilmaz
EKEda Karadag-Oncel
Eda Karadag-Oncel
NDNihal Olgac Dundar
Nihal Olgac Dundar
PGPINAR GENCPINAR
PINAR GENCPINAR
BSBerrak Sarioglu
Berrak Sarioglu
DÇDilek Çavuşoğlu
Dilek Çavuşoğlu

25 July 2019 in International Journal of Neuroscience
Verified
Journal Article
Closed access
TÖTaha Reşid Özdemir
Taha Reşid Özdemir
PGPINAR GENCPINAR
PINAR GENCPINAR
PAPınar Arıcan
Pınar Arıcan
ÖÖÖzgür Öztekin
Özgür Öztekin
NDNihal Olgac Dundar
Nihal Olgac Dundar
BOBerk Ozyilmaz
Berk Ozyilmaz
Hereditary spastic paraplegia (HSP) is a group of rare neurodegenerative disorder with genetic and clinical heterogeneity. It has autosomal dominant (AD), autosomal recessive (AR) and X-linked forms. HSPs are clinically classified into 'pure' and 'complicated' (complex) forms. SPG11 (KIAA1840) and SPG15 (ZFYVE26) are the most common ARHSPs with thin corpus callosum (TCC). They typically present with early cognitive impairment in childhood followed by gait impairment and spasticity in the second and third decades of life. Here, we present a patient girl, born to a couple who were first cousins, was admitted to the pediatric neurology outpatient clinic at 14 years of age because of walking with help, dysarthria and forgetfulness. Her examination revealed a motor mental retardation, bilateral leg spasticity, increased deep tendon reflexes in lower limbs, bilateral pigmentary retinopathy; TCC and white matter hyperintensities on brain MRI, sensorimotor axonal polyneuropathy findings in lower limbs on electromyography. Based on the clinical features and the imaging studies, the diagnosis of HSP was suspected. Targeted next generation sequencing (NGS) was performed using Inherited NGS Panel that consists of 579 gene associated with Mendelian disorders. Analysis of the patient revealed a c.6398_6401delGGGA(p.Arg2133Asnfs*15)(Exon35) homozygous novel change in ZFYVE26 gene. Genotype-phenotype correlation of HSP is complicated due to heterogeneity. The clinical similarity of HSP types increases the importance of genetic diagnosis. There are few reports about pathogenic variants in ZFYVE26 gene in the literature. This case report is one of the few studies that revealed a novel pathogenic variant in ZFYVE26 gene using NGS.

15 June 2023 in Clinical and Experimental Health Sciences
Verified
Journal Article
Closed access
SASenem Ayça
Senem Ayça
SYSemra Yüksel
Semra Yüksel
HNHatice Yaşat Nacar
Hatice Yaşat Nacar
PAPınar Arican
Pınar Arican
Objective: The effects of prenatal coronavirus 2019 disease (COVID-19) exposure on the infantile neurological development are unknown. It has been considered that the inflammatory, thrombotic, and vascular changes occurred in the placentas taken from pregnant women diagnosed with COVID-19 and the inflammatory nature of COVID-19 infection may lead to negative obstetric and neurological events. We aimed to assess the potential neurological effects of prenatal COVID-19 exposure on the infant. Methods: The present study included 2–12-month-old infants born to women with positive real-time reverse transcription polymerase chain reaction test results for COVID-19 from the population of pregnant patients under routine follow-up. The neurological examinations and the Denver II Developmental Screening Test (DDST II) were performed for 41 infants aged 2–12 months to assess the neurological effects of prenatal COVID-19 exposure. Results: The average gestational age of the infants was 38.7 ± 1.9 weeks, and the average birth weight was 3198 ± 543 g. Eight of the infants had a history of hospitalization in the neonatal intensive care unit. The neurological examination and the neuromotor development of 40 (96%) infants were normal for their age group. Only one infant had abnormal neurological examination and DDST II result. Conclusion: The findings of the study suggest that prenatal COVID-19 exposure has no negative neurological impact on infants. Long-term prospective studies with larger sample sizes are needed for more comprehensive assessment of the neurological effects of prenatal COVID-19 exposure on the infants.

30 December 2022 in Çocuk ve Medeniyet Dergisi
Verified
Journal Article
Open access
PDF file
PAPınar Arıcan
Pınar Arıcan
Dünya çapında 1,4 milyon çocuğun kör olduğu ve bunların dörtte üçünün gelişmekte olan ülkelerden olduğu tahmin edilmektedir. Görme bozukluğu, sosyal etkileşimi sınırlayabilir ve bireylerin sosyal ve duygusal gelişimini olumsuz etkileyebilir. Görme bozukluğu olan çocuklar, gören yaşıtlarına göre daha fazla duygusal ve davranışsal zorluklarla karşılaşabilirler. Çocuklarda körlük nispeten nadir olmakla birlikte, engellilik yılları açısından birey, aile ve toplum üzerinde ağır bir yük oluşturur. Koruyucu önlemlerin gerekliliği ve göz hastalığı olan çocukların erken teşhisi ve tedavisinin önemi konusunda her düzeydeki sağlık çalışanlarının farkındalığının artırılması esastır. Cerrahi olarak tedavi edilebilir durumları yönetmek ve görme engelliler için destek imkanı sağlamak için uygun eğitim, tesis, ekipman ve uzman kişiler gereklidir.

30 September 2024 in Journal of Child Neurology
Verified
Journal Article
Closed access
PGPinar Gencpinar
Pinar Gencpinar
PAPinar Arican
Pinar Arican
NDNihal Olgac Dundar
Nihal Olgac Dundar
BKBetül Kılıç
Betül Kılıç
ESEsra Sarigecili
Esra Sarigecili
HTHasan Tekgul
Hasan Tekgul
Objective: This study aimed to assess the first-drug efficacy rate in newly diagnosed children with epilepsies treated with antiseizure medications. Methods: This retrospective study was conducted on 1003 children (age range: 3-10 years, and the mean duration of follow-up: 22 ± 13 months) with newly diagnosed epilepsy. The following parameters were evaluated: first-drug efficacy rate, first-drug-failure rate, and drug resistance rate in the cohort. Results: The first-drug-failure rate was defined in 335/1003 (33%) of the patients, no seizure control in 315 (31%), and drug withdrawal in 20 (2%). There was no significant difference between the group with focal-onset seizures and the group with generalized onset seizures. The first-drug efficacy rate was 67% in children with focal-onset seizures and 66% in children with generalized-onset seizures. Adjunctive antiseizure medication therapy was initiated in 335 patients—dual therapy with 180 patients (18%) and polytherapy with 155 (15%). Drug-resistant epilepsy was defined as 15% in the follow-up period. Etiology-specific diagnoses of the cohort were structural (n = 165, 17%), genetic (n = 25, 3%), metabolic (n = 15%), immune-infectious (n = 17 (2%), and unknown (n = 781, 77%). With a comparison of the 2 most common etiology subgroups (structural versus unknown), a first-drug efficacy rate of 53% and a higher prevalence of drug-resistant epilepsy at 30% were observed in children with structural etiology. First-drug efficacy was statistically lower in children without well-defined epilepsy syndromes (65%) compared with the rate of those with well-defined epilepsy syndrome (79%). Conclusion: This study revealed a first-drug failure rate (33%) in the presented cohort with a drug-resistance epilepsy rate (15%).

15 July 2026
Verified
Book
Open access
PDF file
SKSerkan Kırık
Serkan Kırık
FSFatma Sargın
Fatma Sargın
HFHurşit Ferahkaya
Hurşit Ferahkaya
AGAhmet Sami Güven
Ahmet Sami Güven
MŞMürşide Şahin
Mürşide Şahin
ÖYÖzlem Ateş Yaman
Özlem Ateş Yaman